These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37862877)

  • 1. The association between community social vulnerability and prescription opioid availability with individual opioid overdose.
    El Ibrahimi S; Hendricks MA; Little K; Ritter GA; Flores D; Loy B; Wright D; Weiner SG
    Drug Alcohol Depend; 2023 Nov; 252():110991. PubMed ID: 37862877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Household Opioid Availability With Opioid Overdose.
    Hendricks MA; El Ibrahimi S; Ritter GA; Flores D; Fischer MA; Weiss RD; Wright DA; Weiner SG
    JAMA Netw Open; 2023 Mar; 6(3):e233385. PubMed ID: 36930154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.
    Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS
    Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
    Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
    JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Opioid Overdose After an Initial Opioid Prescription.
    Weiner SG; El Ibrahimi S; Hendricks MA; Hallvik SE; Hildebran C; Fischer MA; Weiss RD; Boyer EW; Kreiner PW; Wright DA; Flores DP; Ritter GA
    JAMA Netw Open; 2022 Jan; 5(1):e2145691. PubMed ID: 35089351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.
    Adams JW; Duprey M; Khan S; Cance J; Rice DP; Bobashev G
    Harm Reduct J; 2023 Oct; 20(1):150. PubMed ID: 37848945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying bright spot communities: Socioecological, workforce, and healthcare delivery factors influencing opioid mortality.
    Britz J; Krist A; Chapman D; Moeller F; Bethune C; Sabo R; Harrell A; Lowe J; Richards A; Saunders H; Woolf S
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release.
    McLeod KE; Buxton JA; Karim ME; Martin RE; Nosyk B; Kurz M; Scow M; Felicella G; Slaunwhite AK
    PLoS One; 2024; 19(7):e0306075. PubMed ID: 38985687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
    Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
    Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Racial/Ethnic and Income Disparities in the Prescription of Opioids and Other Controlled Medications in California.
    Friedman J; Kim D; Schneberk T; Bourgois P; Shin M; Celious A; Schriger DL
    JAMA Intern Med; 2019 Apr; 179(4):469-476. PubMed ID: 30742196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
    Alexander GC; Ballreich J; Mansour O; Dowdy DW
    Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
    Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
    Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Kumar A; Linas BP; Morgan JR; Murphy SM; Walley AY; Yan S; Schackman BR; Marshall BDL
    Addiction; 2022 May; 117(5):1372-1381. PubMed ID: 34825427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of opioid use disorder in Kentucky's counties: A two-year multi-sample capture-recapture analysis.
    Thompson K; Barocas JA; Delcher C; Bae J; Hammerslag L; Wang J; Chandler R; Villani J; Walsh S; Talbert J
    Drug Alcohol Depend; 2023 Jan; 242():109710. PubMed ID: 36469995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.